Lipoxygenase Inhibitory Activity Evaluation of Achillea Biebersteinii Afan. by Activity-Guided Fractionation
| dc.contributor.author | Subasi, Bilgen | |
| dc.contributor.author | Gunbatan, Tugba | |
| dc.contributor.author | Gurbuz, Ihan | |
| dc.contributor.author | Dilmac, Elif | |
| dc.contributor.author | Bedir, Erdal | |
| dc.contributor.author | Demirci, Fatih | |
| dc.date.accessioned | 2025-12-25T21:39:41Z | |
| dc.date.available | 2025-12-25T21:39:41Z | |
| dc.date.issued | 2026 | |
| dc.description.abstract | Ethnopharmacological relevance: Achillea biebersteinii Afan. is traditionally utilized as folk medicine for a broad range of therapeutic applications, especially for promoting the maturation of abscesses, wound healing; against inflammation, and rheumatism in T & uuml;rkiye. Aim of the study: The anti-inflammatory potential of A. biebersteinii was evaluated through activity-guided fractionation (AGF) targeting lipoxygenase (15-LOX) inhibition. Materials and methods: Different chromatographic techniques were used for the AGF of the ethyl acetate extract of A. biebersteinii aerial parts. The in vitro 15-LOX inhibitory activity evaluation was performed to address the antiinflammatory activity. The structures of purified compounds from the fractions were confirmed by LC-HRMS, 1H NMR, and 13C NMR analyses, respectively. Results: The fractionation and isolation process culminated in the identification of three key flavonoids namely; patulitrin, axillarin, quercetagetin-7-O-beta-glucopyranoside, and 4,5-dicaffeoylquinic acid, which showed statistically remarkable 15-LOX inhibitory activity with inhibition rates of 82.27%, 96.81 %, 84.65% and 77.47 %, respectively. Two flavonoids were isolated by using the AGF method, where quinic acid was spotted to have significant 15-LOX inhibitory activity. Conclusion: These findings support the future therapeutic potential of A. biebersteinii as a natural antiinflammatory source. | en_US |
| dc.identifier.doi | 10.1016/j.jep.2025.120900 | |
| dc.identifier.issn | 0378-8741 | |
| dc.identifier.issn | 1872-7573 | |
| dc.identifier.scopus | 2-s2.0-105023667036 | |
| dc.identifier.uri | https://doi.org/10.1016/j.jep.2025.120900 | |
| dc.identifier.uri | https://hdl.handle.net/11147/18776 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Ireland Ltd | en_US |
| dc.relation.ispartof | Journal of Ethnopharmacology | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Achillea Biebersteinii | en_US |
| dc.subject | Patulitrin | en_US |
| dc.subject | Axillarin | en_US |
| dc.subject | Quercetagetin-7-O-Beta-Glucopyranosidne | en_US |
| dc.subject | 4, 5-Dicaffeoylquinic Acid | en_US |
| dc.subject | Lipoxygenase | en_US |
| dc.subject | Anti-Inflammatory | en_US |
| dc.title | Lipoxygenase Inhibitory Activity Evaluation of Achillea Biebersteinii Afan. by Activity-Guided Fractionation | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.scopusid | 59925410100 | |
| gdc.author.scopusid | 57188819718 | |
| gdc.author.scopusid | 6602792411 | |
| gdc.author.scopusid | 57216417618 | |
| gdc.author.scopusid | 7003998497 | |
| gdc.author.scopusid | 35071145000 | |
| gdc.author.wosid | Demirci, Fatih/Jmp-7081-2023 | |
| gdc.author.wosid | Günbatan, Tuğba/Aha-9058-2022 | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Institute of Technology | en_US |
| gdc.description.departmenttemp | [Subasi, Bilgen] Minist Natl Def Pharmaceut Factory Directorate, TR-06110 Ankara, Turkiye; [Gunbatan, Tugba; Gurbuz, Ihan; Bedir, Erdal] Gazi Univ, Fac Pharm, Dept Pharmacognosy, TR-06330 Ankara, Turkiye; [Dilmac, Elif] Izmir Inst Technol, Dept Bioengn, TR-35430 Izmir, Turkiye; [Demirci, Fatih] Anadolu Univ, Fac Pharm, Dept Pharmacognosy, TR-26470 Eskisehir, Turkiye | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.volume | 357 | en_US |
| gdc.description.woscitationindex | Science Citation Index Expanded | |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.openalex | W4416303479 | |
| gdc.identifier.pmid | 41241211 | |
| gdc.identifier.wos | WOS:001621798800001 | |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.openalex.collaboration | National | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.scopuscites | 0 | |
| gdc.scopus.citedcount | 0 | |
| gdc.wos.citedcount | 0 | |
| relation.isAuthorOfPublication.latestForDiscovery | 461a570d-2493-4349-b634-a876ced8cd22 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 9af2b05f-28ac-4015-8abe-a4dfe192da5e |
